-
Pogacar expects Vingegaard Tour de France battle to last 'years'
-
Japan deploys bear cameras in mountains as attacks surge
-
New York ready for epic Swift-Kelce love story wedding
-
Djokovic has history in his sights at Wimbledon
-
Wildfires rage in southern France, 3,000 people evacuated
-
Ovechkin returning to Caps for 22nd NHL season
-
Hamilton gives F1 a piece of his mind over Lego cars
-
Faster than Mbappe: Australia flyer Bos races into World Cup conversation
-
Hong Kong bookseller once held in China dies in Taiwan
-
Trump wants 'senseless killing' in Ukraine to end: US official
-
Venezuelan rescue brings hope to nation in mourning
-
Eala writes history for Philippines in 'electric' Wimbledon atmosphere
-
Macabre night in La Guaira, Venezuela's earthquake epicenter
-
Wolff urges 'perspective' as Russell chases Mercedes' teammate Antonelli
-
Tesla global auto sales jump 25% in 2nd quarter, beating expectations
-
Superb Swiatek, Zverev cruise into Wimbledon last 32
-
Zverev routs Royer to reach Wimbledon third round
-
Ukraine, Russia vow escalation after Moscow attack kills 21 in Kyiv
-
Hot spell roasts eastern US ahead of holiday weekend
-
Slowing US job growth poses midterms challenge for Trump
-
Hamilton cools fans Ferrari fervour
-
Klopp poised to replace Nagelsmann as Germany coach: reports
-
Venezuela's diaspora searches for quake victims on social media
-
More than 400 dead in DR Congo's spreading Ebola outbreak
-
Albanian clashes as protest over Trump-linked resort boils over
-
Hot spell roasts eastern US as holiday weekend approaches
-
Desire key to Pogacar dominance, says former Tour king Froome
-
Superb Swiatek storms into Wimbledon last 32, Zverev waits
-
Rescuers dig out Venezuelan man eight days after quakes
-
Russian strikes kill 21 in biggest ever attack on Kyiv, mayor says
-
Anderson closes in on record Man City move
-
Swiatek sees off Pliskova to race into Wimbledon third round
-
England change five for South Africa Test
-
Dollar down, stocks shine after disappointing US jobs data
-
Lock Alemanno to make 100th Pumas appearance against Scotland
-
US job growth slows, posing questions for Trump before midterms
-
US posts weaker-than-expected job growth in June
-
Chanel eyes menswear with Charvet shirtmaker takeover
-
UK PM says 'deeply sorry' for decades of forced adoptions
-
Chanel eyes menswear with Charvet shirtmaker takevoer
-
Almost 1.2 mn apply for Spain's migrant regularisation
-
'I grabbed my child': Kyiv residents face devastation of biggest Russian barrage of war
-
Ukrainian state ordered Nord Stream sabotage: German prosecutors
-
Former top jockey Dettori breaks ribs in car crash
-
Swiatek, Zverev aiming to lay down Wimbledon markers
-
Rees-Zammit returns to wing as Wales face Fiji
-
German ruling coalition agrees on major reform package
-
Renovations on historic Paris Opera house extended by three years
-
European stocks climb after Asia rout
-
Thailand denies viral claim Macron knelt before king
Abortion pill at center of escalating US court battle
Federal judges in Texas and Washington on Friday issued dueling rulings that intensified the legal battle over abortion and a commonly used medical abortion drug.
The legal battle over the pill mifepristone has grown more intense since the US Supreme Court last year tossed out the federal right to the procedure.
The abortion pill was at the center of two conflicting federal court rulings on Friday.
In one ruling, a federal judge in Texas halted Food and Drug Administration approval of the abortion pill, pending a seven-day window to give the Justice Department time to appeal.
Then Friday night, in a dramatic lurch in a different legal direction, a federal judge in Washington state said that the FDA must keep the abortion pill available in at least 12 liberal states.
Here is background on the abortion pill and its use.
- How widespread is abortion pill use? -
According to the Guttmacher Institute, the pill accounted for more than half -- 53 percent -- of the 930,160 abortions documented by the reproductive health research and policy organization in the United States in 2020.
That was up from 17 percent in 2008 and 39 percent in 2017.
While the number of so-called medication abortions has gone up dramatically in the United States in recent years, it is still not as prevalent as in several European nations.
In France, for example, medication abortions represented 70 percent of the total number of abortions in 2020.
- How does it work? -
The abortion pill is different from the "morning after" pill, which is taken by a woman after sexual intercourse to prevent becoming pregnant.
The abortion pill is taken to induce an abortion once a woman confirms that she is pregnant.
It in fact involves more than one pill. The first, mifepristone, also known as RU 486, stops a pregnancy from proceeding normally by blocking production of the hormone progesterone.
Another drug, misoprostol, is taken up to 48 hours later and causes cramps, bleeding and the emptying of the uterus.
Abortion pills can be used at home and a medical setting is not required.
- When was the abortion pill approved? -
The US Food and Drug Administration (FDA) gave the green light to mifepristone and misoprostol in 2000.
It is approved for use up to 10 weeks of pregnancy, after which a woman would need to undergo an abortion through another means such as vacuum aspiration.
The average cost of a medication abortion at Planned Parenthood is $580 but it can cost up to $800.
- Is it safe and effective? -
Use of the abortion pill during the specified time period is considered to be safe and effective by medical experts.
Pregnancies are successfully terminated in more than 95 percent of cases where the pill is used, according to studies.
Serious complications -- excessive bleeding, fever, infection or allergic reaction -- which require a medical consult, are rare.
The abortion pill does not work for ectopic pregnancies, which account for around two percent of all pregnancies and where a fertilized egg grows outside the uterus.
- Where is the pill available? -
At least 13 US states have banned most abortions, including medication abortions, since the Supreme Court's ruling in June overturning the constitutional right to an abortion.
Despite the bans, a number of organizations have mobilized to provide abortion pills to women in states where abortion is restricted.
The extent of their efforts is difficult to evaluate.
In the states where abortion is legal, the FDA recently loosened restrictions surrounding mifepristone, allowing it to be sent through the mail with a prescription or to be sold directly in pharmacies like any other drug.
S.Keller--BTB